Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

608
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
608
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

532
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
532
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

399
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
399

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using actigraphy to evaluate physical activity in patients with pleural effusion: a pilot study.

Journal of thoracic disease·2026
Same author

Impact of using waist-to-height ratio for diagnosing obesity in general digestive outpatient consultations.

Revista espanola de enfermedades digestivas·2026
Same author

Exposure to bisphenol A in European women from 2007 to 2014 using human biomonitoring data - The European Joint Programme HBM4EU.

Environment international·2024
Same author

Gravity- vs Wall Suction-Driven Large-Volume Thoracentesis: A Randomized Controlled Study.

Chest·2024
Same author

Assessing mucosal recovery in celiac disease - Time to diagnosis and histological severity as determining factors.

Revista espanola de enfermedades digestivas·2024
Same author

Consumption of Tritordeum Bread Reduces Immunogenic Gluten Intake without Altering the Gut Microbiota.

Foods (Basel, Switzerland)·2022

Related Experiment Video

Updated: Dec 8, 2025

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

24.8K

New celiac disease biomarkers.

Laura Rodríguez-Martín1, Luis Vaquero2, Santiago Vivas2

  • 1Aparato Digestivo, Complejo Asistencial Universitario de León, León.

Revista Espanola De Enfermedades Digestivas
|September 21, 2020
PubMed
Summary

New biomarkers show promise for diagnosing and monitoring celiac disease, potentially improving upon current methods like antibody tests and biopsies. This review explores their clinical utility for celiac patients.

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.1K
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

2.9K

Related Experiment Videos

Last Updated: Dec 8, 2025

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

24.8K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.1K
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

2.9K

Area of Science:

  • Immunology
  • Gastroenterology
  • Clinical Diagnostics

Background:

  • Celiac disease diagnosis relies on anti-tissue transglutaminase and anti-deaminated gliadin antibodies, HLA-DQ genetics, and duodenal biopsies.
  • Current diagnostic tools sometimes present challenges in accurately diagnosing and managing celiac disease patients.
  • There is a need for improved biomarkers to enhance diagnostic accuracy and patient follow-up.

Purpose of the Study:

  • To review the scientific evidence for novel biomarkers in celiac disease.
  • To evaluate the potential clinical utility of these biomarkers in diagnosis and patient follow-up.
  • To explore biomarkers based on their pathophysiological relation to intestinal damage and immune response.

Main Methods:

  • Literature review of scientific evidence on celiac disease biomarkers.
  • Analysis of biomarkers evaluated for their pathophysiological relevance to intestinal damage.
  • Assessment of biomarkers related to the immune response in celiac disease.
  • Evaluation of the clinical utility of biomarkers for diagnosis and follow-up.

Main Results:

  • Established biomarkers include anti-tissue transglutaminase antibodies, anti-deaminated gliadin antibodies, HLA-DQ genotyping, and duodenal biopsies.
  • Emerging biomarkers are being investigated for their role in understanding celiac disease pathophysiology.
  • The clinical utility of various biomarkers for diagnosis and monitoring is under review.

Conclusions:

  • While current markers are foundational, challenges in celiac disease diagnosis and follow-up necessitate further biomarker research.
  • Biomarkers linked to intestinal damage and immune response show potential for clinical application.
  • Continued investigation into novel biomarkers may improve the management of celiac disease.